Fresenius Ventures
Fresenius
◆ Investment Thesis
Invest in healthcare startups across new therapeutic modalities, microbiome research, precision nutrition and digital care solutions adjacent to Fresenius' three strategic platforms: biopharma, medtech and care provision.
◆ About Fresenius
Fresenius Ventures is a corporate venture capital fund established by Fresenius to expand its access to innovation networks. With an intended investment volume of more than €200 million over the next five years, it focuses on high-potential healthcare innovators and technologies that align with Fresenius' strategic goals.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Michael Sen | CEO | Executive | |
| Thomas Michael Thestrup | Managing Director | Senior |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Fresenius Ventures invest in?
Fresenius Ventures invests in Biotech, Digital Health, Medtech, Drug Discovery and Diagnostics at the pre-seed, seed, series-a, series-b and growth stages.
Which geographies does Fresenius Ventures focus on?
Fresenius Ventures focuses on Europe and North America, and is headquartered in Germany.
What is Fresenius Ventures's typical check size?
Fresenius Ventures typically writes checks of $0.5M to $10M.